Health News
Anti-Seizure Rx Potiga Linked to Retinal Abnormalities and Blue Skin Discoloration
The US Food and Drug Administration (FDA) is warning the public that the anti-seizure medication Potiga (ezogabine) can cause blue skin discoloration and eye abnormalities characterized by pigment changes in the retina.
FDA does not currently know if these changes are reversible. All patients taking Potiga should have a baseline eye exam, followed by periodic eye exams.
Pigment changes in the retina have the potential to cause serious eye disease with loss of vision. It is not yet known whether the retinal pigment changes caused by Potiga lead to visual impairment, although several pa...
Pediatricians Weigh in on Home Birth
Home births in the US have been increasing, but how safe is it to have a baby at home? Do these children have less access to emergency care if needed.
Safety First Means Sober Driving
Sober drivers get in car crashes every day. Adding alcohol, drugs or prescription medications to the equation can really compound the risk for winding up in a wreck.
Do I Have an Ectopic Pregnancy?
A life-threatening condition in women is an ectopic pregnancy. However, it can be difficult for a woman to know if she has become pregnant and that the embryo has not implanted in her uterus.
A Pregnancy Dilemma for a Medication?
Some medications are linked to disorders such as autism or to birth defects when taken during pregnancy. However, that risk must also be balanced against the medication's benefits.
FDA Launches Partnership to Protect Against Counterfeit Anti-Malarial Medicines
The US Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.
FDA Approves Second Drug in BD Simplist
BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the US Food and Drug Administration (FDA) has approved the second drug to be offered in the recently launched BD Simplist™ line of ready-to-administer prefilled generic injectables.
No Spoonful of Medicine for the Kiddo
It can be frustrating to watch your toddler or your baby suffer from a cold or a bad cough. But giving them over-the-counter medicines is not usually a good idea.
OTC Painkillers Aren’t Marathon Candy
Just because a painkiller can be bought over-the-counter doesn’t mean that it can't hurt the body. Marathon runners that take preventive painkillers may be at risk for bad reactions.
Nora Apothecary & Alternative Therapies Announces Recall of Compound Products
Nora Apothecary & Alternative Therapies today announced a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product.